Generic Pharmaceutical Business Investment Opportunities

• Manufacturer and exporter of homeopathic OTC products, offering a wide portfolio including single remedy pills, dilutions, tablets, pellets, family kits, and blank sugar globules. • Operates as a digitally native, direct-to-consumer (D2C) brand with sales infrastructure built for its own website and major US marketplaces such as Amazon, eBay, and Walmart. • Holds a rare multinational structure with legal entities in the United States, India, and Canada, enabling global operations and regulatory alignment. • Manufacturing facility in India is US FDA registered and has undergone multiple inspections, with only minor observations in the latest review and clearance expected to resume exports. • Owns a US FDA Drug Master File (Type IV) for homeopathic blank pellets, positioning the business as a qualified global supplier of pharmaceutical-grade excipients. • Portfolio includes thousands of OTC SKUs listed with the US FDA, reflecting significant product depth and regulatory groundwork. • Brand is a registered trademark in the United States, strengthening intellectual property protection and market positioning. • Demonstrates strong customer validation through high ratings across major marketplaces and its own platform, indicating product acceptance despite pre-revenue status. • US-based fulfillment center is FDA-inspected with no observations, capable of handling large-scale order volumes and compliant with cGMP standards including recalls and complaint handling. • Backed by a founding team with decades of domain experience in homeopathy and established industry presence. • Built a scalable proprietary e-commerce infrastructure integrated with production systems and third-party platforms, ready to support high SKU and order volumes. • Currently pre-revenue with no sales recorded yet from the India facility; regulatory processes including US FDA inspection are in progress.

• Manufacturer and exporter of homeopathic OTC products, offering a wide portfolio including single remedy pills, dilutions, tablets, pellets, family kits, and blank sugar globules. • Operates as a digitally native, direct-to-consumer (D2C) brand with sales infrastructure built for its own website and major US marketplaces such as Amazon, eBay, and Walmart. • Holds a rare multinational structure with legal entities in the United States, India, and Canada, enabling global operations and regulatory alignment. • Manufacturing facility in India is US FDA registered and has undergone multiple inspections, with only minor observations in the latest review and clearance expected to resume exports. • Owns a US FDA Drug Master File (Type IV) for homeopathic blank pellets, positioning the business as a qualified global supplier of pharmaceutical-grade excipients. • Portfolio includes thousands of OTC SKUs listed with the US FDA, reflecting significant product depth and regulatory groundwork. • Brand is a registered trademark in the United States, strengthening intellectual property protection and market positioning. • Demonstrates strong customer validation through high ratings across major marketplaces and its own platform, indicating product acceptance despite pre-revenue status. • US-based fulfillment center is FDA-inspected with no observations, capable of handling large-scale order volumes and compliant with cGMP standards including recalls and complaint handling. • Backed by a founding team with decades of domain experience in homeopathy and established industry presence. • Built a scalable proprietary e-commerce infrastructure integrated with production systems and third-party platforms, ready to support high SKU and order volumes. • Currently pre-revenue with no sales recorded yet from the India facility; regulatory processes including US FDA inspection are in progress.

Pharmaceutical manufacturing company producing a wide range of formulations for domestic and international markets. - Operates on a B2B model supplying distributors, pharma companies, and healthcare businesses. - Serves 100+ clients globally and exports products to more than 20 countries. - Handles approximately 30–35 orders per month across different markets. - Manufacturing facility is WHO-GMP certified and designed to meet international quality standards. - Strong presence in ROW (Rest of World) markets with ongoing export operations. - Registered under the Ministry of Corporate Affairs and holds valid GST registration. - Holds required pharmaceutical manufacturing approvals including WHO-GMP certification and USFDA compliance for export-related operations.

Business will operate from a self-owned facility on leased land. - The new plant, Designed to meet USFDA & EU-GMP requirements, is a Greenfield project with a land size of 240,000 sq ft on a 99-year lease. - The built-up area spans 90,000 sq ft and is located in Dewas. - Its scope includes manufacturing oral powder sachets, effervescent tablets, oral liquids, tablets, and capsules, all designed for global compliance. - The promoter have extensive pharmaceutical manufacturing, marketing & distribution experience and an able leadership and marketing team.

Established over 30 years ago, the business specializes in the manufacturing of generic pharmaceuticals, focusing on ophthalmic sterile preparations and healthcare products. - Located in Dhanu Rd, Thane, the company operates with a small but dedicated team of employees committed to quality and innovation. - The product line includes over 100 items, featuring eye and ear drops, nasal sprays, tablets, capsules, and syrups designed for various health and wellness applications. - The company holds expertise in producing ophthalmic sterile preparations, which are essential for ensuring safety and effectiveness in eye and ear treatments. - Products are marketed under the company’s own brand name, enhancing brand recognition in the pharmaceutical industry. - The business generates revenue through direct sales to pharmacies, hospitals, and healthcare providers, providing essential health solutions for consumers. - Business has a manufacturing license and registration certificate.

Operates a pharmaceutical manufacturing unit in Nalagarh, Baddi with WHO-GMP, GLP and ISO certifications. - Produces tablets, capsules, liquid orals, ointments and a CEFA dry powder injection line for government supply, domestic buyers and export clients. - Facility is designed as a general section layout with controlled environments for multiple dosage forms. - Current handling capacity is around 1000 cartons across product categories. - Holds Food and Drug licenses along with active registration on the MCA portal. - Positioned to serve institutional orders and private-label requirements with compliant processes and quality documentation. - Experienced team manages regulatory, technical and quality operations with a focus on international standards. - The business faced legal issues five years ago related to the manufacturing of COVID vaccines. Since then, the charges have been dropped, and it is now legally clear to operate.

The company is engaged in the business of haemostatic medicines, contraceptives, and calcium tablets. - We do not manufacture the products ourselves and rely on a third-party manufacturer. - Our business operates on a B2B model, selling products to stockists. - Currently, we have 19 stockist clients. - Revenue is generated primarily through bulk sales. - The company is a private limited entity with GST and MSME registration. - We are not USFDA approved.

The company is in a pre-revenue phase and will engage in pharmaceutical manufacturing and packaging. - We will establish a transformative generic medicine facility with rapid-changeover capabilities and low capital requirements. - Operations will focus on emerging and frontier markets, especially high-growth regions like Africa. - We will import exclusively from the USA, Canada, and Europe. - All manufacturing will meet local, FDA, and EU cGMP standards to obtain WHO certification. - Once the investment is secured, we will register the company and begin operations.

Business is located in Bhubaneswar, specializing in the development of drugs that induce endogenous nitric oxide in humans and animals. - Company is incubated in a well-known biotechnological institute in Bhubaneswar, Orissa. - Company has successfully completed the research to identify the chemical structure of the drug that can induce nitric oxide production and is now seeking funding to proceed with development. - Research findings are patented and protected in India, USA, and EU, providing the company with a competitive advantage in the market. - The company is ready to commence the development phase upon securing the necessary funding, presenting an opportunity for potential investors to participate in an innovative and potentially lucrative venture in the pharmaceutical and nutraceutical industry. - Promoter is a medical researcher and has 50 years of experience. - The company is registered with the Ministry of Corporate Affairs (MCA), ensuring compliance with regulatory and legal requirements.

The business operates in the pharmaceutical and medical devices export industry, focusing on therapies such as anaemia management, nephrology, and gynaecology. - With a current staff of 6 permanent employees, the business has made significant strides in increasing its client base, growing from 2 clients in the last fiscal year to 15 clients in the current fiscal year. - The company has outlined a road-map to achieve a turnover of 100 crore in the next 2 fiscal years, indicating a strong growth trajectory. - Initially starting as a short-term trading model, the business is now transitioning towards brand building and is in the process of registering its brand in 4 countries, showcasing a strategic shift in its business model. - The product portfolio comprises 80% medicines and 20% medical devices, with a focus on exporting these products to countries such as Zambia, Uganda, and Kenya. - The business sources medicines and equipment from India and exports them to international markets, highlighting its role in facilitating the global distribution of pharmaceutical and medical devices. - With a valid GST certificate for operations, the business is compliant with regulatory requirements, adding a layer of credibility to its operations.